“Molecular-Docking Study of quinazolin-4(3H)-one derivatives against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 5, pp. 572–575, Sep. 2020, doi: 10.25004/IJPSDR.2020.120521.